Fig. 7From: A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenarioTumor-infiltrating cells. Mice from PBS and CHOP×2 groups were sacrificed at day 45 p.t.i., and tumors were removed to study tumor-infiltrating cell populations. Percentage of CD4+ T cells (CD3+ CD4+ lymphocytes), CD8+ T cells (CD3+ CD8+ lymphocytes), NK cells (CD3− CD49b+ lymphocytes), Tregs (CD3+ CD4+ CD25+ FoxP3+ lymphocytes), and neutrophils (Gr1+ CD11b+ cells), determined by flow cytometry. Results are shown as mean ± standard deviation (n = 5). Significant differences between groups were observed for CD4+ (p = 0.0023) and CD8+ T cells (p = 0.0034)Back to article page